I studie II sås ACR 20 respons hos 88% af patienterne (291/ 332), ACR 50 hos 62% (205/ 332) og ACR 70 hos 38% (127/ 334) ved 24 måneder.
In study II, ACR 20 responses were observed in 88% (291/ 332) of patients, ACR 50 in 62% (205/ 332), and ACR 70 in 38% (127/ 334) at 24 months.